Gopa Iyer Selected Research

Gopa Iyer Research Topics

Disease

68	Neoplasms (Cancer) 04/2024 - 12/2010
32	Carcinoma (Carcinomatosis) 03/2024 - 06/2011
29	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 10/2012
7	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 02/2013
5	Disease Progression 03/2024 - 01/2018
3	Carcinogenesis 12/2017 - 12/2010
2	Small Cell Carcinoma 10/2022 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 04/2013
2	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 11/2016
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2016 - 07/2014
2	Breast Neoplasms (Breast Cancer) 02/2015 - 02/2014
1	Body Weight (Weight, Body) 03/2024
1	Neoplasm Micrometastasis 01/2023
1	Stomatitis 01/2023
1	Urachal adenocarcinoma 01/2022
1	Central Serous Chorioretinopathy 12/2021
1	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2021
1	Microsatellite Instability 01/2021
1	Perivascular Epithelioid Cell Neoplasms 10/2018
1	Angiomyolipoma 10/2018
1	Rare Diseases (Rare Disease) 10/2018
1	Non-Muscle Invasive Bladder Neoplasms 12/2017
1	Sarcoma (Soft Tissue Sarcoma) 10/2017
1	Adenocarcinoma 11/2016
1	Colonic Neoplasms (Colon Cancer) 11/2016

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2016
17	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 07/2014
13	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2018
12	PlatinumIBA 03/2024 - 12/2010
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2014
6	Gemcitabine FDA Link 04/2024 - 01/2018
6	Phosphotransferases (Kinase)IBA 10/2020 - 02/2013
4	NivolumabIBA 12/2023 - 10/2018
3	ChromatinIBA 12/2022 - 02/2015
3	B7-H1 AntigenIBA 01/2022 - 01/2017
3	atezolizumabIBA 01/2022 - 01/2017
3	Everolimus FDA Link 01/2021 - 10/2012
3	AntibodiesIBA 01/2019 - 06/2018
2	Carboplatin (JM8)FDA LinkGeneric 03/2024 - 12/2017
2	pembrolizumabIBA 03/2024 - 01/2019
2	erdafitinibIBA 11/2023 - 01/2023
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 12/2015
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 05/2021 - 12/2020
2	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2021
2	NVP-BKM120IBA 10/2020 - 12/2017
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 12/2015
2	taxaneIBA 01/2018 - 12/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 07/2014
2	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2015 - 02/2013
2	TOR Serine-Threonine KinasesIBA 08/2013 - 10/2012
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2013 - 06/2011
1	enfortumab vedotinIBA 03/2024
1	sitravatinibIBA 12/2023
1	cyclopropapyrroloindoleIBA 12/2023
1	binimetinibIBA 10/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	Circulating Tumor DNAIBA 12/2022
1	Transcription Factors (Transcription Factor)IBA 11/2022
1	peposertibIBA 01/2022
1	Blocking AntibodiesIBA 01/2021
1	tremelimumabIBA 01/2021
1	durvalumabIBA 01/2021
1	irofulvenIBA 01/2021
1	Biological FactorsIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	IpilimumabIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 10/2020
1	LigandsIBA 01/2019
1	MTOR InhibitorsIBA 10/2018
1	Immunomodulating AgentsIBA 06/2018
1	Estrogen ReceptorsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2017
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Dihydrotestosterone (Androstanolone)IBA 11/2016
1	AndrogensIBA 11/2016
1	enzalutamideIBA 11/2016
1	ErbB Receptors (EGF Receptor)IBA 11/2016
1	Monoclonal AntibodiesIBA 11/2016
1	Epidermal Growth Factor (EGF)IBA 11/2016
1	Formaldehyde (Formol)FDA Link 11/2016
1	ParaffinIBA 11/2016

Therapy/Procedure

33	Therapeutics 04/2024 - 12/2010
27	Drug Therapy (Chemotherapy) 04/2024 - 12/2010
12	Cystectomy 04/2024 - 10/2014
12	Neoadjuvant Therapy 04/2024 - 01/2018
11	Immunotherapy 11/2022 - 04/2016
2	Lymph Node Excision (Lymph Node Dissection) 10/2020 - 08/2017
2	Nephroureterectomy 01/2019 - 01/2016
2	Salvage Therapy 11/2016 - 02/2016
1	Adjuvant Chemotherapy 10/2022
1	Chemoradiotherapy 10/2022
1	Precision Medicine 01/2021
1	Radiotherapy 01/2019
1	Aftercare (After-Treatment) 01/2017